Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients

• Status: Recruiting
• Trial end date: 2029-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The objectives are to compare the results of the Gastric By-Pass (GBP) to that of optimized medical therapy in patients with obesity and poorly controlled type 2 diabetes in terms of mortality, weight loss, glycemic control, quality of life, cost, cost-effectiveness and cost utility of these two strategies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Lille

Criteria

Inclusion Criteria:

• Type 2 diabetes mellitus with HbA1c > 7.5 %

• Body mass index > 35 and < 50 kg/m2

• Candidate for Gastric By-Pass

• Treatment with GLP1 (glucagon-like peptide) analogue or insulin

Exclusion Criteria:

• Contraindication to bariatric surgery

• Pregnancy

• Affiliation of health care assurance

• Psychiatric disorders